Cargando…
Current Advances and Future Prospects in Cancer Immunotherapeutics
Cancer is a disease that results from the uncontrolled proliferation and growth of cells. Due to early detection methods, there is a decrease in death rates in many types of cancer. However, among the causes of death worldwide, cancer still ranks second after cardiovascular diseases. Therefore, canc...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064104/ https://www.ncbi.nlm.nih.gov/pubmed/36974661 http://dx.doi.org/10.4274/MMJ.galenos.2023.29599 |
_version_ | 1785017838946222080 |
---|---|
author | DEDE, Zeynep TUMER, Kader KAN, Tugce YUCEL, Burcu |
author_facet | DEDE, Zeynep TUMER, Kader KAN, Tugce YUCEL, Burcu |
author_sort | DEDE, Zeynep |
collection | PubMed |
description | Cancer is a disease that results from the uncontrolled proliferation and growth of cells. Due to early detection methods, there is a decrease in death rates in many types of cancer. However, among the causes of death worldwide, cancer still ranks second after cardiovascular diseases. Therefore, cancer research has focused mainly on developing more effective treatments to reduce deaths from cancer. With a better understanding of the molecular mechanisms in cancer cells, advances in cancer treatment have evolved and changed. The main priority of research is to develop treatment modalities with the highest response rate and less side effects. In this context, immunotherapies have started a new era in cancer treatments. In this review, an overview of the future of next-generation treatment methods is presented by including the most preferred immunotherapy methods. |
format | Online Article Text |
id | pubmed-10064104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-100641042023-04-01 Current Advances and Future Prospects in Cancer Immunotherapeutics DEDE, Zeynep TUMER, Kader KAN, Tugce YUCEL, Burcu Medeni Med J Review Cancer is a disease that results from the uncontrolled proliferation and growth of cells. Due to early detection methods, there is a decrease in death rates in many types of cancer. However, among the causes of death worldwide, cancer still ranks second after cardiovascular diseases. Therefore, cancer research has focused mainly on developing more effective treatments to reduce deaths from cancer. With a better understanding of the molecular mechanisms in cancer cells, advances in cancer treatment have evolved and changed. The main priority of research is to develop treatment modalities with the highest response rate and less side effects. In this context, immunotherapies have started a new era in cancer treatments. In this review, an overview of the future of next-generation treatment methods is presented by including the most preferred immunotherapy methods. Galenos Publishing 2023-03 2023-03-27 /pmc/articles/PMC10064104/ /pubmed/36974661 http://dx.doi.org/10.4274/MMJ.galenos.2023.29599 Text en © Copyright 2023 by the Istanbul Medeniyet University / Medeniyet Medical Journal published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc/4.0/Licenced by Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) |
spellingShingle | Review DEDE, Zeynep TUMER, Kader KAN, Tugce YUCEL, Burcu Current Advances and Future Prospects in Cancer Immunotherapeutics |
title | Current Advances and Future Prospects in Cancer Immunotherapeutics |
title_full | Current Advances and Future Prospects in Cancer Immunotherapeutics |
title_fullStr | Current Advances and Future Prospects in Cancer Immunotherapeutics |
title_full_unstemmed | Current Advances and Future Prospects in Cancer Immunotherapeutics |
title_short | Current Advances and Future Prospects in Cancer Immunotherapeutics |
title_sort | current advances and future prospects in cancer immunotherapeutics |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064104/ https://www.ncbi.nlm.nih.gov/pubmed/36974661 http://dx.doi.org/10.4274/MMJ.galenos.2023.29599 |
work_keys_str_mv | AT dedezeynep currentadvancesandfutureprospectsincancerimmunotherapeutics AT tumerkader currentadvancesandfutureprospectsincancerimmunotherapeutics AT kantugce currentadvancesandfutureprospectsincancerimmunotherapeutics AT yucelburcu currentadvancesandfutureprospectsincancerimmunotherapeutics |